Geographic trends and risk of gastrointestinal cancer among patients with celiac disease in Europe and Asian-Pacific region

Gastroenterology and Hepatology from Bed to Bench

Volumn 6, Issue 4, 2013, Pages 170-177

  Rostami Nejad, Mohammad ^a   Aldulaimi, David ^b   Ishaq, Sauid ^c   Ehsani Ardakani, Mohammad Javad ^a   Zali, Mohammad Reza ^a   Malekzadeh, Reza ^d   Rostami, Kamran ^e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALEXANDRA HOSPITAL   (United Kingdom)

^c DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Adenocarcinoma; Asian Pacific region; Celiac disease; Europe; Lymphoma

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; IMMUNOGLOBULIN A;

ASIA; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CELIAC DISEASE; CLINICAL EVALUATION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; ENVIRONMENTAL FACTOR; EUROPE; GENETIC RISK; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PACIFIC ISLANDS; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SMALL INTESTINE CARCINOMA; TREND STUDY; TUMOR BIOPSY;

EID: 84884945528     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357: 1731-43.
2. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-92.
3. Rostami K, Malekzadeh R, Shahbazkhani B, Akbari MR, Catassi C. Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder? Dig Liver Dis 2004; 36: 694-97.
4. Rostami Nejad M, Rostami K, Emami MH, Zali MR, Malekzadeh R. Epidemiology of Celiac disease in Iran; A Review. Middle East Journal of Digestive Diseases 2011;3: 74-77.
5. Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol 2011;3:33-42.
6. Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a populationbased cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002; 123: 1428-35.
7. Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol. 2011; 3:33-42.
8. Elfström P, Granath F, Ye W, Ludvigsson JF. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol 2012;10:30-36.
9. Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med 2003; 115: 191-95.
10. Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006; 38:374-80.
11. Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-19.
12. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 2004; 329: 716-19.
13. Silano M, Volta U, Vincenzi AD, Dessì M, Vincenzi MD; Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci 2008;53:972-76.
14. Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005;54:54-59.
15. Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006;15:2069-77.
16. Delco F, El-Serag HB, Sonnenberg A. Celiac sprue among US military veterans: associated disorders and clinical manifestations. Dig Dis Sci 1999;44:966-72.
17. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001;358:356-61.
18. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20:769-75.
19. Gao Y, Kristinsson SY, Goldin LR, Björkholm M, Caporaso NE, Landgren O. Increased risk for non- Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology 2009;136:91-98.
20. Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, Mcmahon DJ, Absan H, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001;96:126-31.
21. Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009;302:1171-78.
22. Freeman HJ. Adult celiac disease in the elderly. World J Gastroenterol 2008;14:6911-14.
23. Swinson CM, Slavin G, Coles EC, Booth CC. Coeliac disease and malignancy. Lancet 1983;1:111-15.
24. Solaymani-Dodaran M, West J, Logan RF. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am J Gastroenterol 2007;102:864-70.
25. Grainge MJ, West J, Solaymani-Dodaran M, Card TR, Logan RF. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment PharmacolTher 2012; 35:730-39.
26. Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Jewell D. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study. Eur J Gastroenterol Hepatol 2008;20:297-304.
27. Lohi S, Maki M, Rissanen H, Knekt P, Reunanen A, Kaukinen K. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med 2009;41:508-15.
28. Godfrey JD, Brantner TL, Brinjikji W, Christensen KN, Brogan DL, Van Dyke CT, et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2005;139:763-69.
29. Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011;117:1163-71.
30. Elli L, Contiero P, Tagliabue G, Tomba C, Bardella MT. Risk of intestinal lymphoma in undiagnosed coeliac disease: Results from a registered population with different coeliac disease prevalence. Dig Liver Dis 2012;44:743-7.
31. Canavan C, Logan RF, Khaw KT, West J. No difference in mortality in undetected coeliac disease compared with the general population: a UK cohort study. Aliment Pharmacol Ther 2011; 34:1012-19.
32. Lohi S, Mäki M, Montonen J, Knekt P, Pukkala E, Reunanen A, et al. Malignancies in cases with screeningidentified evidence of coeliac disease: a long-term population-based cohort study. Gut 2009;58:643-47.
33. Lebwohl B, Stavsky E, Neugut AI, Green PH. Risk of colorectal adenomas in patients with coeliac disease. Aliment Pharmacol Ther 2010;32:1037-43.
34. Ludvigsson J, West J, Ekbom A, Stephansson O. Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease. Int J Cancer 2012; 131: 244-50.
35. Anderson LA, McMillan SA, Watson RG, Monaghan P, Gavin AT, Fox C, et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity." World J Gastroenterol 2007;13:146-51.
36. Cil T, Altintas A, Isikdogan A, Pasa S, Bayan K, Batun S, et al. Screening for Celiac disease in Hodgkin and non-Hodgkin lymphoma patients. Turk J Gastroenterol 2009; 20:87-92.
37. Farre C, Domingo-Domenech E, Font R, Marques T, Fernandez de Sevilla A, Alvaro T, et al. Celiac disease and lymphoma risk: a multicentric case-control study in Spain. Dig Dis Sci 2004;49:408-12.
38. Mearin ML, Catassi C, Brousse N, Brand R, Collin P, Fabiani E, et al. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol 2006; 18:187-94.
39. Howdle PD, Jalal PK, Holmes GK, Houlston RS. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 2003; 96: 345-53.
40. Schweizer JJ, Oren A, Mearin ML; Working Group for Celiac Disease and Malignancy of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Cancer in children with celiac disease: a survey of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2001;33:97-100.
41. Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol 2009; 24:1347-51.
42. Takeshita M, Nakamura S, Kikuma K, Nakayama Y, Nimura S, Yao T, et al. Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan. Histopathology 2011;58:395-407.
43. Wu J, Xia B, von Blomberg BM, Zhao C, Yang XW, Crusius JB, et al. Coeliac disease in China, a field waiting for exploration. Rev Esp Enferm Dig 2010; 102:472-7.
44. Selby WS, Gallagher ND. Malignancy in a 19-year experience of adult celiac disease. Dig Dis Sci 1979;24:684-88.
45. Rajabalinia H, Fatemi SR, Shahbazi SH, Bahreiny R, Dabiri R, Ghobakhlou M, et al. Duodenal Adenocarcinoma is the important cause of intractable nausea and vomiting in patient with Coeliac disease. Gastrointerol Hepatol Bed Bench 2012; 5:144-49.
46. Makishima H, Komiyama Y, Asano N, Momose K, Nakamura S, Ishida F. Peripheral T-cell lymphoma following diffuse large b-cell lymphoma associated with celiac disease. Intern Med 2008;47(4):295-8.
47. Sun J, Lu Z, Yang D, Chen J. Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Erratum in Mod Pathol 2011;24:1284.
48. Masjedizadeh R, Hajiani E, Hashemi J, Shayesteh AK, Moula K, Rajabi T. Celiac disease in South-West of Iran. World J Gastroenterol 2006; 12: 4416-19.
49. Jafroodi M, Zargari O, Hoda S. Concomitant Hodgkin's Lymphoma and Atopic Dermatitis in a Childwith Celiac Disease. Arch Iranian Med 2009; 12:317-319.
50. Tse E, Gill H, Loong F, Kim SJ, Ng SB, Tang T, et al. Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol 2012;87:663-68.
51. Holtmeier W. (Treatment and management of celiac disease) Z Gastroenterol 2006; 44: 1167-75.
52. Rostami Nejad M, Rostami K, Pourhoseingholi MA, Nazemalhosseini E, Dabiri H, Habibi M, et al. Atypical presentation is dominant and typical for Celiac Disease. J Gastrointestin Liver Dis 2009; 18: 285-91.
53. Loftus CG, Loftus EV. Cancer risk in celiac disease. Gastroenterology 2004; 123: 1726-29.
54. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease--effect of a gluten free diet. Gut 1989; 30: 333-38.
55. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people withcoeliac disease: population based cohort study. BMJ 2004; 329:716-19.
56. Silano M, Volta U, Mecchia AM, Dessì M, Di Benedetto R, De Vincenzi M. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 2007;7:8.
57. Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98:51-60.
58. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac diseasein a population-based Swedish cohort. Arch Intern Med 2003 163:1566-72.